Lynne Marie Sullivan insider trades: Unity Biotechnology (UBX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lynne reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | UBX | ↓ Sell | 21,867 | $1.03 | $23K | Direct | Apr 3, 2025 (1d) |
| Feb 4, 2025 | UBX | ↓ Sell | 153 | $2.23 | $341 | Direct | Feb 5, 2025 (1d) |
| Nov 4, 2024 | UBX | ↓ Sell | 136 | $1.29 | $175 | Direct | Nov 6, 2024 (2d) |
| Aug 2, 2024 | UBX | ↓ Sell | 139 | $1.53 | $213 | Direct | Aug 6, 2024 (4d) |
| Jun 25, 2024 | UBX | ↓ Sell | 324 | $1.40 | $454 | Direct | Jun 26, 2024 (1d) |
| Jul 28, 2021 | PHGE | ↑ Buy | 12,500 | $4.00 | $50K | Direct | Jul 30, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lynne Marie Sullivan's insider trades
Lynne Marie Sullivan is CFO & Head of Corp. Dev. at Unity Biotechnology (UBX). Since Jul 28, 2021, Lynne has reported 1 open-market purchase worth $50K and 5 sales worth $24K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (30 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.